The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial - Su, Yanbing; Zhang, Jianxing; Wang, Huanwei; Gu, Yangkui; Ouyang, Handong; Huang, Wan (Annals of Translational Medicine, 2022)